Overview
The Parliamentary Standing Committee on Health and Family Welfare submitted its 176th report on the Affordability and Accessibility of Healthcare Facilities in Public and Private Sector. Chaired by Ram Gopal Yadav, the committee warned that aggressive corporatisation of private hospitals, driven by FDI, could raise treatment costs and hurt affordability.
Key Developments
- Recommend a strict review and rationalisation of FDI in the operation and acquisition of existing private hospitals.
- Encourage foreign capital in manufacturing of medical devices, consumables and rare‑disease medicines, but keep tighter scrutiny on hospital ownership.
- Suggest incentives – tax holidays, soft loans, subsidised land and electricity – to set up multi‑speciality hospitals in tier‑2, tier‑3 and rural areas.
- Propose a mandatory increase in reserved beds for BPL, EWS and AB‑PMJAY beneficiaries from 10% to 20%.
- Call for autonomous public multi‑speciality hospitals in every revenue division to act as a price regulator.
- Recommend PPP models for advanced technologies in underserved regions and cross‑subsidisation of poorer patients by higher‑paying ones.
Important Facts
The 80th round of the NSS shows the average cost of a private‑hospital stay at ₹50,508, while a government hospital stay costs only ₹6,631. The committee also notes weak enforcement of existing bed‑reservation norms and calls for a single‑window clearance system for smaller cities.
Exam Relevance
This report touches on several GS topics: the role of FDI in health‑care (GS3), the functioning of parliamentary committees and policy‑making (GS2), the ethics of equitable health access and cross‑subsidisation (GS4), and the impact of public‑private dynamics on service delivery (GS2 & GS3). Understanding these linkages helps answer questions on health‑sector reforms, fiscal incentives, and social justice.
Way Forward
To balance investment with affordability, the government should:
- Finalize revised FDI caps for hospital operations.
- Channel foreign funds into medical‑device and drug manufacturing rather than hospital ownership.
- Strengthen public hospital networks to provide a low‑cost alternative and exert price pressure on private players.
- Implement robust monitoring of bed‑reservation and price‑capping mechanisms, with penalties for non‑compliance.
- Promote transparent PPP contracts that mandate affordable care for vulnerable groups.
These steps aim to ensure that foreign capital supplements, not supplants, public investment, thereby safeguarding affordable health care for all citizens.